Novel Regulators of GPCR Signaling in Hematopoietic Stem Cells
造血干细胞中 GPCR 信号传导的新型调节剂
基本信息
- 批准号:10023156
- 负责人:
- 金额:$ 6.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-16 至 2022-09-15
- 项目状态:已结题
- 来源:
- 关键词:AddressAftercareAgonistApoptosisBindingBiochemicalBioinformaticsBiological AssayBiotinBloodBone MarrowC-terminalCRISPR/Cas technologyCXCR4 geneCell CycleCell TransplantationCell physiologyCellsCellular biologyChimera organismChimeric ProteinsChimerismComplexDataData SetDiseaseDopamineDown-RegulationEducational process of instructingEducational workshopElectroporationEndocytosisEngraftmentEnvironmentFellowshipFlow CytometryFrequenciesG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesHematological DiseaseHematopoieticHematopoietic Stem Cell TransplantationHematopoietic SystemHematopoietic stem cellsHomingHumanImmunofluorescence ImmunologicK-562Knock-outLabelLaboratoriesLifeLigandsLysosomesMass Spectrum AnalysisMentorsMethodsModelingMolecularMusNervous system structureOpioidOutcomeOutputPathway interactionsPhenotypePostdoctoral FellowProceduresProductionProteinsProteomicsRecyclingRegimenRegulationResistanceResource DevelopmentResourcesRoleSaint Jude Children&aposs Research HospitalSamplingSavingsSerumSignal TransductionSignaling ProteinSorting - Cell MovementStem cell transplantSupporting CellTailTestingTimeTrainingTransplantationUmbilical Cord BloodWorkWritingXenograft procedurecareer developmentchronic myeloid leukemia cellconditioningcurative treatmentsexperiencehuman cord blood CD34+ cellimprovedin vivoinsertion/deletion mutationinterestknock-downleukemia treatmentmultipotent cellnovelperipheral bloodpost-transplantprotein transportreceptorreconstitutionself renewing cellsmall hairpin RNAsuccesstargeted sequencingtherapeutic targettraffickingtraining opportunity
项目摘要
Project Summary
Hematopoietic stem and progenitor cells (HSPCs) are self-renewing, transplantable cells that support lifelong
blood production. HSPC function and transplantation are tied to signal transduction through G-protein coupled
receptors (GPCRs), particularly that of CXCR4 which regulates homing and niche retention. Our understanding
of basic GPCR regulatory mechanisms in these cells are lacking. This is highlighted by our laboratories recent
finding that two GPCR-trafficking proteins, GPRASP1 and GPRASP2, act as negative regulators of HSPC
transplantation. Our preliminary data further indicate that these proteins limit HSPC quiescence and resistance
to apoptosis in a CXCR4-dependent manner. GPRASP1 and -2 have been described in the nervous system to
promote the lysosomal degradation and functional downregulation of opioid, dopamine, and other select
receptors. The receptors regulated by GPRASP1 and -2 in HSCs are currently unknown. As a postdoctoral fellow
in the McKinney-Freeman laboratory, I will investigate the molecular functions of GPRASP1 and -2 in HSPCs.
In Aim 1, I will use biochemical methods to definethe impact of GPRASP1 and -2 on CXCR4 signaling. The
impact of GPRASP1 and -2 on CXCR4 endocytosis, degradation, and downstream signaling outcomes after
agonist stimulation will be analyzed in mouse HSPCs. In Aim 2, I will probe the role of GPRASP1 and -2 in
transplantation of human HSPCs isolated from cord blood. Human HSPCs that have undergone gene editing by
CRISPR/Cas9 nucleofection to knockout GPRASP1 or -2 and will be used in competitive xenotransplantation
assays. By following the relative engraftment and blood production of wild type and knockout human HSPCs
after xenotransplantation the impact of GPRASP proteins on this procedure will be determined. In Aim 3, I will
use an unbiased proteomics approach to investigate the receptor targets of GPRASP1 and -2, as well as the
downstream trafficking pathways associated with these proteins. Biotin proximity labeling will be performed using
GPRASP-APEX fusion proteins in K562 chronic myelogenous leukemia cells both before and at multiple
timepoints following agonist stimulation. Biotinylated samples will undergo Tandem Mass Tagging and multiplex
mass spectrometry to determine the relative abundance of proteins across timepoints. This will allow for
bioinformatic analysis of the receptor targets and downstream trafficking pathways associated with GPRASP1
and -2. All protein associations of interest will be validated by immunofluorescence in mouse HSPCs. These
aims draw on my prior training as a biochemist but provide abundant training opportunities in the field of HSPC
biology. The McKinney-Freeman laboratory and St. Jude are ideal environments in which to receive training in
HSPC biology. Institutional resources provided, including state-of-the-art flow cytometry and proteomics cores,
will greatly contribute to the success of this project. In addition, I will take advantage of numerous career
development resources during my fellowship. These resources include scientific writing workshops, presentation
and networking opportunities, and teaching and mentoring experiences.
项目摘要
造血茎和祖细胞(HSPC)是自我更新的可移植细胞,可支持终身
血液产生。 HSPC功能和移植通过G蛋白耦合而绑定到信号转导
受体(GPCR),特别是调节归巢和利基保留率的CXCR4的受体。我们的理解
这些细胞中缺乏基本的GPCR调节机制。我们的实验室最近强调了这一点
发现两种GPCR贩运蛋白GPRASP1和GPRASP2充当HSPC的负调节剂
移植。我们的初步数据进一步表明这些蛋白质限制了HSPC静止和抗性
以CXCR4依赖性方式凋亡。神经系统中已经描述了GPRASP1和-2
促进阿片类药物,多巴胺和其他选择的溶酶体降解和功能下调
受体。 HSC中由GPRASP1和-2调节的受体目前尚不清楚。作为博士后研究员
在麦金尼 - 弗里曼实验室中,我将研究HSPC中GPRASP1和-2的分子功能。
在AIM 1中,我将使用生化方法来定义GPRASP1和-2对CXCR4信号的影响。这
GPRASP1和-2对CXCR4内吞作用,降解和下游信号的影响
激动剂刺激将在小鼠HSPC中进行分析。在AIM 2中,我将探讨GPRASP1和-2在
从脐带血中分离出的人类HSPC的移植。经过基因编辑的人类HSPC
crispr/cas9核对敲除gprasp1或-2,将用于竞争性异种移植
测定。通过遵循野生型和敲除人类HSPC的相对植入和血液产生
异种移植后,将确定GPRASP蛋白对此过程的影响。在AIM 3中,我会
使用公正的蛋白质组学方法研究GPRASP1和-2的受体靶标,以及
与这些蛋白质相关的下游运输途径。将使用生物素接近标签
K562中的Gprasp-Apex融合蛋白在多个之前和多个
激动剂刺激后的时间点。生物素化样品将经过串联质量标记和多重
质谱法确定跨时间的蛋白质相对丰度。这将允许
与GPRASP1相关的受体靶标和下游运输途径的生物信息学分析
和-2。所有感兴趣的蛋白质关联将通过小鼠HSPC中的免疫荧光来验证。这些
目的借鉴了我作为生物化学家的先前培训,但在HSPC领域提供了丰富的培训机会
生物学。麦金尼 - 弗里曼实验室和圣裘德是接受培训的理想环境
HSPC生物学。提供的机构资源,包括最先进的流式细胞术和蛋白质组学核心,
将有助于该项目的成功。此外,我将利用许多职业
在我的奖学金期间开发资源。这些资源包括科学写作研讨会,演讲
以及网络机会,教学和指导经验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher David Nevitt其他文献
Christopher David Nevitt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher David Nevitt', 18)}}的其他基金
Novel Regulators of GPCR Signaling in Hematopoietic Stem Cells
造血干细胞中 GPCR 信号传导的新型调节剂
- 批准号:
10254425 - 财政年份:2019
- 资助金额:
$ 6.53万 - 项目类别:
Novel Regulators of GPCR Signaling in Hematopoietic Stem Cells
造血干细胞中 GPCR 信号传导的新型调节剂
- 批准号:
9910878 - 财政年份:2019
- 资助金额:
$ 6.53万 - 项目类别:
相似国自然基金
面向掌纹识别的安全与隐私保护理论和方法研究
- 批准号:62376211
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
微观市场均衡视角下中国长期护理保险试点的福利分析与政策评估
- 批准号:72304093
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向康复护理机器人的人机信任度评估方法与任务影响机制研究
- 批准号:62306195
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于生命质量的癌症患者心理行为与护理干预
- 批准号:72381240026
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:国际(地区)合作与交流项目
天然水体中药品和个人护理品间接光降解产物预测模型的构建和应用
- 批准号:42307496
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/Cancer
项目3:绝经前妇女肥胖和子宫内膜增生/癌症的一级预防和子宫保留
- 批准号:
10711638 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
TLR5增强肝脏定向放疗加免疫检查点阻断治疗受照射的肝转移和远隔肿瘤
- 批准号:
10630642 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
The OUD Cascade of Care and Critical Outcomes: Longitudinal Linkage with Opioid Use
OUD 护理和关键成果级联:与阿片类药物使用的纵向联系
- 批准号:
10741268 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别: